Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
NCT01947881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71
Last updated 2017-03-13
Summary
The purpose of this study is to identify Diabetic Macular Edema (DME) characteristics in eyes that show different response to treatment with anti-VEGF (vascular endothelial growth factor) injections of Lucentis.
Conditions
Sponsors & Collaborators
-
Association for Innovation and Biomedical Research on Light and Image
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-10-31
Countries
- Portugal
Study Locations
More Related Trials
-
New Concepts in Diabetic Macular Edema (DME)
NCT04186702 ·Status: COMPLETED ·Phase: NA
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
NCT01331681 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
NCT03780361 ·Status: COMPLETED ·Phase: PHASE4
-
Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema
NCT07096713 ·Status: COMPLETED ·Phase: NA
-
Evaluation of RC28-E Injection in Diabetic Macular Edema
NCT04782115 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN
-
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
NCT02194634 ·Status: UNKNOWN ·Phase: PHASE3
-
Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome
NCT05080803 ·Status: COMPLETED
-
Assessment of Color Vision in Diabetic Patients
NCT03345667 ·Status: COMPLETED
-
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
NCT01783886 ·Status: COMPLETED ·Phase: PHASE3
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema
NCT01824862 ·Status: COMPLETED
-
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
NCT03927690 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
NCT01473251 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema
NCT02874859 ·Status: COMPLETED
-
Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema
NCT05271539 ·Status: COMPLETED ·Phase: PHASE3
-
Glycemic Control and Diabetic Macular Edema
NCT01358396 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
NCT06908876 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
NCT02121262 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
NCT03097068 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients
NCT06879301 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
NCT03246152 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study
NCT02308644 ·Status: COMPLETED ·Phase: PHASE3